Spinal Nrf2 translocation may inhibit neuronal NF-κB activation and alleviate allodynia in a rat model of bone cancer pain.
Spinal Nrf2 translocation may inhibit neuronal NF-κB activation and alleviate allodynia in a rat model of bone cancer pain.
复制标题
脊髓Nrf 2转位可能抑制神经元NF-κB活化并减轻骨癌痛大鼠模型的异常性疼痛。
DOI:
10.1111/jnc.15468
复制
发表时间:
2021-09
影响因子:
4.7
通讯作者:
Yao, Ming
中科院分区:
文献类型:
--
作者:
Fu, Jie;Ni, Chaobo;Ni, Hua-Dong;Xu, Long-Sheng;He, Qiu-Li;Pan, Huan;Huang, Dong-Dong;Sun, Yan-Bao;Luo, Ge;Liu, Ming-Juan;Yao, Ming
Bone cancer pain (BCP) is a clinical pathology that urgently needs to be solved, but research on the mechanism of BCP has so far achieved limited success. Nuclear factor erythroid 2 (NFE2)‐related factor 2 (Nrf2) has been shown to be involved in pain, but its involvement in BCP and the specific mechanism have yet to be examined. This study aimed to test the hypothesis that BCP induces the transfer of Nrf2 from the cytoplasm to the nucleus and further promotes nuclear transcription to activate heme oxygenase‐1 (HO‐1) and inhibit the activation of nuclear factor‐kappa B (NF‐κB) signalling, ultimately regulating the neuroinflammatory response. Von‐Frey was used for behavioural analysis in rats with BCP, whereas western blotting, real‐time quantitative PCR (RT‐PCR) and enzyme‐linked immunosorbent assay (ELISA) were used to detect molecular expression changes, and immunofluorescence was used to detect cellular localization. We demonstrated that BCP induced increased Nrf2 nuclear protein expression with decreased cytoplasmic protein expression in the spinal cord. Further increases in Nrf2 nuclear protein expression can alleviate hyperalgesia and activate HO‐1 to inhibit the expression of NF‐κB nuclear protein and inflammatory factors. Strikingly, intrathecal administration of the corresponding siRNA reversed the above effects. In addition, the results of double immune labelling revealed that Nrf2 and NF‐κB were coexpressed in spinal cord neurons of rats with BCP. In summary, these findings suggest that the entry of Nrf2 into the nucleus promotes the expression of HO‐1, inhibiting activation of the NF‐κB signalling pathway, reducing neuroinflammation and ultimately exerting an anti‐nociceptive effect. We propose that Nrf2 (Nuclear factor erythroid 2 (NFE2)‐related factor 2) regulates NF‐κB (Nuclear factor‐kappa B) activation to attenuate neuroinflammation and bone cancer pain (BCP): Bone cancer–induced oxidative stress drives the dissociation of Nrf2 with Keap‐1 (kelch‐like ECH‐related protein 1) and transcription to the nucleus in spinal cord neurons, thereby initiating the body's defence response. Further promoting Nrf2 entry into the nucleus could increase HO‐1 (heme oxygenase‐1) expression to inhibit NF‐κB activation and downstream inflammatory factor release in spinal cord neurons and finally reduce pain. We believe that these findings can help provide new therapeutic strategies for the treatment of BCP.
登录
查看更多内容
DOI:
10.1016/j.bbi.2014.06.199
发表时间:
2014-11
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
Allette YM;Due MR;Wilson SM;Feldman P;Ripsch MS;Khanna R;White FA
通讯作者:
White FA
影响因子:
5.8
作者:
Lewis, Kate M.;Harford-Wright, Elizabeth;Ghabriel, Mounir N.
通讯作者:
Ghabriel, Mounir N.
影响因子:
5.1
作者:
Chen, Yajun;Chen, Hongguang;Wang, Guolin
通讯作者:
Wang, Guolin
影响因子:
5.6
作者:
Bellezza, Ilaria;Tucci, Arianna;Minelli, Alba
通讯作者:
Minelli, Alba
DOI:
10.1007/s00018-016-2223-0
发表时间:
2016-09
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
作者:
Loboda A;Damulewicz M;Pyza E;Jozkowicz A;Dulak J
通讯作者:
Dulak J